Heike Lehrmann
Impact in
- Molecular Biology top 10%
- RNA Interference and Gene Delivery
- Histone Deacetylase Inhibitors Research
- Advanced biosensing and bioanalysis techniques
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Viral Infectious Diseases and Gene Expression in Insects
- Ubiquitin and proteasome pathways
- Genetics top 10%
- Virus-based gene therapy research
Papers in
-
- RNA Interference and Gene Delivery 5
- Advanced biosensing and bioanalysis techniques 3
- Viral Infectious Diseases and Gene Expression in Insects 3
- Histone Deacetylase Inhibitors Research 2
- CRISPR and Genetic Engineering 2
- Ubiquitin and proteasome pathways 2
- Genomics and Chromatin Dynamics 2
- Genetics 6
- Virus-based gene therapy research 5
- Co-authors
- Annick Harel‐Bellan (4 shared papers)Matthew Cotten (5 shared papers)Anna Polesskaya (1 shared paper)Linda L. Pritchard (1 shared paper)Mediyha Saltik (2 shared papers)Thierry Tchénio (1 shared paper)Guillermina Lozano (1 shared paper)Luis A. Martinez (1 shared paper)
- Journals
- Journal of Virology (2 papers)Human Gene Therapy (1 paper)International Journal of Pharmaceutics (1 paper)Cellular and Molecular Life Sciences (1 paper)Advances in cancer research (1 paper)
- Partner nations
- FranceAustriaUnited States
In The Last Decade
Heike Lehrmann
10 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 942
- Genetics 306
- Oncology 174
- Cancer Research 77
- Immunology 90
Countries citing papers authored by Heike Lehrmann
This map shows the geographic impact of Heike Lehrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heike Lehrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heike Lehrmann more than expected).
Fields of papers citing papers by Heike Lehrmann
This network shows the impact of papers produced by Heike Lehrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heike Lehrmann. The network helps show where Heike Lehrmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Heike Lehrmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 274 | |
| 2 | 1997 | 169 | |
| 3 | 2002 | 168 | |
| 4 | 2002 | 161 | |
| 5 | 1999 | 82 | |
| 6 | 1999 | 77 | |
| 7 | 1997 | 60 | |
| 8 | 2003 | 50 | |
| 9 | 1999 | 27 | |
| 10 | 2006 | 12 |
About Heike Lehrmann
Heike Lehrmann is a scholar working on Molecular Biology, Genetics, Epidemiology, Cell Biology and Immunology, having authored 10 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), Virus-based gene therapy research (5 papers), Advanced biosensing and bioanalysis techniques (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Histone Deacetylase Inhibitors Research (2 papers), CRISPR and Genetic Engineering (2 papers), Ubiquitin and proteasome pathways (2 papers) and Genomics and Chromatin Dynamics (2 papers). The work is most often cited by research in Molecular Biology (942 citations), Genetics (306 citations), Oncology (174 citations), Cancer Research (77 citations) and Immunology (90 citations). Heike Lehrmann has collaborated with scholars based in France, Austria and United States. Frequent co-authors include Annick Harel‐Bellan, Matthew Cotten, Anna Polesskaya, Linda L. Pritchard, Mediyha Saltik, Thierry Tchénio, Guillermina Lozano, Luis A. Martinez, Irina Naguibneva and Gábor M. Lamm. Their work appears in journals such as Journal of Virology, Human Gene Therapy, International Journal of Pharmaceutics, Cellular and Molecular Life Sciences and Advances in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.